COTA Announces New Financing from Deerfield Management and Prior Investors To Accelerate Cancer Research and Treatment Innovation

 Financing will be used to accelerate and further diversify COTA’s oncology real-world data products and services COTA, Inc., an oncology real-world data and analytics company, announced its latest financing by an investment fund managed by Deerfield Management, a healthcare investment firm. Deerfield invests across the life science, medical device, diagnostic, digital health, and health service industries at every stage of evolution. In conjunction, COTA announced it has raised additional capital from existing investors. The company will use this new funding to further expand its real-world data platform and services in order to drive more efficient and inclusive drug development in oncology. “COTA is an early leader in the oncology real-world data space helping to revolutionize the use of data to improve care and outcomes for cancer patients,” said Leslie Henshaw, Partner at Deerfield Management. “We believe in their mission to bring clarity to cancer care for all patients and are proud to support the expansion of their work.” Miruna Sasu, COTA’s President and CEO, shared how these resources will help improve care and treatment for people facing cancer: “We’ve worked tirelessly to expand the volume and types of data that we offer both our pharma and provider collaborators. Our latest financing and product and services growth will help ensure that COTA’s already robust, diverse, and representative dataset will continue to expand and deliver meaningful in...
Source: EMR and HIPAA - Category: Information Technology Authors: Tags: Genomics-Precision Medicine Health IT Company Healthcare IT Baptist Health South Florida Bristol-Myers Squibb Clinicogenomics COTA COTA Inc. data analytics Deerfield Deerfield Management EMA European Medicines Agency FDA Food a Source Type: blogs